Five equine researchers in the US have received a $15,000 grant to study infectious diseases in the horse from drug maker Boehringer Ingelheim Vetmedica, Inc. (BIVI), under its 2013 Advancement of Equine Research Awards.
An independent panel of equine practitioners, university professors and veterinary medicine researchers selected the recipients. The awards were announced at the recent American Association of Equine Practitioners Annual Convention in Nashville, Tennessee.
“Infectious diseases are an ongoing challenge for equine practitioners and horse owners, which is why they have always been a high priority for our company,” says Steve Grubbs, DVM, PhD, DACVIM, equine technical manager, BIVI.
“Along with our review board, I am impressed by both the quality of this year’s proposals and the innovative approaches to the problem. We look forward to working with these outstanding researchers to find practical solutions that ultimately can improve the quality of life for horses.”
Over the past three years, the company has given $225,000 in Advancement of Equine Research Awards.
The following researchers received awards for 2013:
- Noah Cohen, VMD, MPH, PhD, DACVIM, professor at Texas A&M University, for “Is Diversity of the fecal microbiome associated with risk of Rhodoccocus equi foal pneumonia?”.
- Nicola Pusterla, DVM, PhD, DACVIM, professor at the University of California, Davis, for “Investigation of the presence of novel viruses in nasal secretions of horses with infectious upper respiratory tract disease”.
- David Horohov, PhD, professor at the University of Kentucky, for “Subisotypic differences in the immunoglobulin G response to Lawsonia intracellularis in vaccinated, seropositive and clinically affected horses”.
- Ramiro E. Toribio, DVM, PhD, DACVIM, associate professor at The Ohio State University, for “Dynamics of the equine fecal microbiome in response to antibiotics”.
- Ashely G. Boye, DVM, DACVIM, assistant professor of medicine at the University of Pennsylvania, for “Determining optimal sampling site for strangles carriers using loop-mediated isothermal (LAMP) PCR”.
The awards are open to veterinarians, diagnosticians and public and private researchers in the United States and Canada.
“We are excited about the diversity of this year’s research topics,” Grubbs said. “Infectious diseases are complex problems that require an integrated approach that includes everything from prevention to proper diagnosis to timely vaccinations. I look forward to following the results of these studies as they contribute to future improvements in infectious disease management.”
The topic for the 2014 awards will be announced next spring. Veterinarians, diagnosticians and public and private researchers in the United States and Canada are eligible to submit proposals. Awards will be selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the year-long studies.